N.M. Code R. § 16.10.11.10 – The Physician’s Requirements of Supervision

A. Supervising physicians must provide direction to pharmacist clinicians to specify the pharmacotherapeutic services to be provided under the circumstances in each case. This may be done by written protocol or by oral consultation. It is the responsibility of the supervising physician to assure that the appropriate directions are given and understood.
B. Supervising physicians must establish a quality assurance program for review of medical services provided by the pharmacist clinician.
C. If the supervising physician is of the opinion that circumstances warrant exceptions to the requirements set forth in Subsections A or B above, the supervising physician must specify the circumstances in writing and deliver the same to the board. The board will review, grant or deny requests for exceptions or waivers, at the board’s discretion.
D. Documentation of the supervising physician reviews must be retained by the pharmacist clinician and be available for board inspection for a period of not less than three years from the date of such reviews.
E. The pharmacist clinician must have prompt access to the physician by telephone or other electronic means for advice and direction.
F. If the supervising physician plans to be or is absent from his or her practice for any reason, the supervising physician cannot designate a pharmacist clinician to take over those duties or cover the practice during such absence. The supervising physician may designate an alternate supervising physician, approved by the board, to cover the practice and perform the duties of supervising physician. The alternate supervising physician will then supervise the pharmacist clinician and will be responsible for the pharmacist clinician’s actions or omissions in exercising prescriptive authority or other duties as a pharmacist clinician.
G. Supervising physician is required to report any supervised pharmacist clinician who is practicing below accepted standards of care to the board.
[4/5/1997, 4/27/2000; 16.10.11.10 NMAC - Rn & A, 16 NMAC 10.11.10, 1/10/2007; A, 2/8/2022]